This dual mechanism is the primary reason tirzepatide tends to produce greater weight loss
In the Phase 3 TRIUMPH-4 trial, 33% of participants on the 12 mg dose reported diarrhea compared to 13.4% on placebo (Wang et al., Syst Rev Meta-Analysis, 2025)
HSA/FSA eligible No insurance concierge Cancellation & Refund Policy Keep in mind that they have an automatic autorenewal method
A landmark trial published in the New England Journal of Medicine found that participants using semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, significantly outperforming placebo across all measured outcomes (Wilding et al., NEJM, 2021, Ohio residents across the state, from Clevelands west side to the rural hollows of Appalachian Ohio, have real and practical access to semaglutide today
Here are some tips for the administration of retatrutide in a research setting: Dose consistency: Administer retatrutide at the same time each week to maintain steady blood levels
